Clinical Trial Update: Magnesium Sulphate Neuroprotective Strategies for Preterm Deliveries [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial exploring magnesium sulfate as a neuroprotective strategy for preterm deliveries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Premature Birth

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Zagazig University | Conditions: Premature Birth, NEUROPROTECTION | Phase 2, Phase 3 | Status: UNKNOWN